Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.
Christianne BourlonJeffrey H LiptonUday DeotareVikas GuptaDennis D KimJohn KuruvillaAuro ViswabandyaSanthosh ThyaguHans A MessnerFotios V MichelisPublished in: European journal of haematology (2017)
We conclude that EMD at diagnosis of AML does not seem to influence outcomes following allo-HCT performed in CR1.